In view of the central role of HIF-2α signaling under acidosis (see above), the use of recently developed HIF2α-selective inhibitors, PT2399 and PT2385 (134, 135), also appears as a promising therapeutic approach to selectively kill cancer (stem) cells exposed to acidic conditions. The gene discussed is EPAS1; the disease is cancer.